Publicaciones (66) Publicaciones de MARIA CARMEN MONTESINOS MEZQUITA

2024

  1. Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia

    Biomedicine and Pharmacotherapy, Vol. 173

  2. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model

    Drug Delivery and Translational Research

  3. Osteostatin Mitigates Gouty Arthritis through the Inhibition of Caspase-1 Activation and Upregulation of Nrf2 Expression

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  4. Trends in Scientific Production on Pharmaceutical Follow-up and the Dader Method

    Pharmacy Practice, Vol. 22, Núm. 1

2023

  1. Evolución de la producción científica sobre el seguimiento farmacoterapéutico y el método Dáder

    Ars pharmaceutica, Vol. 64, Núm. 1, pp. 49-49

2021

  1. Activation of the constitutive androstane receptor inhibits leukocyte adhesiveness to dysfunctional endothelium

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

  2. Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A2A Receptors

    Frontiers in Pharmacology, Vol. 12

  3. Cyanocobalamin ultraflexible lipid vesicles: Characterization and in vitro evaluation of drug-skin depth profiles

    Pharmaceutics, Vol. 13, Núm. 3

  4. El inglés como medio de instrucción (EMI) utilizado en el grupo de alto rendimiento académico en el grado de farmacia de la universidad de valencia

    Docencia, ciencia y humanidades: hacia una enseñanza integral en la universidad del siglo XXI (Dykinson), pp. 1370-1387

  5. Elaboración de documentos multimedia sobre noticias farmacológicas como recurso docente

    Universidad, innovación e investigación ante el horizonte 2030 (Egregius)

  6. Elaboración de documentos multimedia sobre noticias farmacológicas como recurso docente

    Docencia, ciencia y humanidades: hacia una enseñanza integral en la universidad del siglo XXI (Dykinson), pp. 1354-1369

  7. English as a Medium of Instruction (EMI) used in the high academic performance group in the Degree in Pharmacy at the University of Valencia

    Universidad, innovación e investigación ante el horizonte 2030 (Egregius)

2020

  1. Improved effectiveness from individualized dosing of self-administered biologics for the treatment of moderate-to-severe psoriasis: a 5-year retrospective chart review from a Spanish University Hospital

    Journal of Dermatological Treatment, Vol. 31, Núm. 4, pp. 370-377

  2. Microneedle‐based delivery: An overview of current applications and trends

    Pharmaceutics, Vol. 12, Núm. 6, pp. 1-28

2019

  1. Defective induction of COX-2 expression by psoriatic fibroblasts promotes pro-inflammatory activation of macrophages

    Frontiers in Immunology, Vol. 10, Núm. MAR

2017

  1. Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis

    Journal of Investigative Dermatology, Vol. 137, Núm. 1, pp. 123-131

2016

  1. Medicinal Plants and Natural Products as Potential Sources for Antiparkinson Drugs

    Planta Medica, Vol. 82, Núm. 11-12, pp. 942-951

  2. Methodological Approach to Use Fresh and Cryopreserved Vessels as Tools to Analyze Pharmacological Modulation of the Angiogenic Growth

    Journal of Cardiovascular Pharmacology, Vol. 68, Núm. 3, pp. 230-240

2015

  1. Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  2. Decreased SAPK/JNK signalling affects cytokine release and STAT3 activation in psoriatic fibroblasts

    Experimental Dermatology